Access Bio Inc (950130) — Cash Flow Reinvestment Rate
Access Bio Inc (950130) has a Cash Flow Reinvestment Rate of 1548.52x as of March 2025, reinvesting ₩8.29 Billion (capex ₩635.11K plus investments ₩8.29 Billion) from operating cash flow of ₩5.35 Million. Check 950130 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Access Bio Inc Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Access Bio Inc across 8 annual periods. Explore investment intensity of Access Bio Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Access Bio Inc (2012–2024)
Year-by-year capital reinvestment analysis for Access Bio Inc. For live market cap and broader valuation context, see how much is Access Bio Inc worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1290.23x | ₩17.47 Billion | ₩13.54 Million | ₩1.40 Million | ▲ +895.2% |
| 2022 | 129.64x | ₩37.77 Billion | ₩291.33 Million | ₩14.90 Million | ▼ -48.9% |
| 2021 | 253.51x | ₩34.96 Billion | ₩137.90 Million | ₩28.76 Million | ▲ +85255.3% |
| 2020 | 0.30x | ₩10.91 Billion | ₩36.72 Billion | ₩10.38 Billion | ▼ -93.7% |
| 2016 | 4.74x | ₩10.03 Million | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩4.85 Billion | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩2.63 Billion | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.31 Billion | ₩1.85 Billion | ₩1.31 Billion | — |